The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anti-CTLA-4 probody BMS-986249 alone or in combination with nivolumab in patients with advanced cancers: Initial phase I results.
 
Martin Gutierrez
Stock and Other Ownership Interests - Cota Healthcare
Honoraria - Foundation Medicine; Guardant Health
Consulting or Advisory Role - Exenex
Speakers' Bureau - Bristol-Myers Squibb; Lilly; Merck
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Checkpoint Therapeutics (Inst); Eisai (Inst); GSB Pharma (Inst); Incyte (Inst); Johnson & Johnson (Inst); MedImmune (Inst); Merck (Inst); Moderna Therapeutics (Inst); NextCure (Inst); Pfizer (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst); Silenseed (Inst)
Travel, Accommodations, Expenses - Guardant Health
 
Georgina V. Long
Honoraria - Bristol-Myers Squibb; Merck; Pierre Fabre
Consulting or Advisory Role - Aduro Biotech; Amgen; Array BioPharma; Bristol-Myers Squibb; GlaxoSmithKline UK Ltd.; Hexal; MERCK; Novartis; OncoSec; Pierre Fabre; Roche
 
Claire Frances Friedman
Consulting or Advisory Role - AstraZeneca/MedImmune
Research Funding - Arcus Biosciences (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst)
Other Relationship - Guidepoint Global
(OPTIONAL) Uncompensated Relationships - Genentech; Merck
 
Donald A. Richards
Consulting or Advisory Role - Ipsen; Seattle Genetics/Astellas; Taiho Pharmaceutical
 
Bradley Corr
Consulting or Advisory Role - Genentech; GlaxoSmithKline (Inst); Novocure (Inst); Tesaro/GSK
Research Funding - Clovis Oncology (Inst)
 
Bruno R. Bastos
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Novartis
Speakers' Bureau - Sanofi/Regeneron
Research Funding - Actuate Therapeutics (Inst); Altor BioScience (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Nektar (Inst); Tolero Pharmaceuticals (Inst); US Oncology (Inst)
 
Marc Isamu Uemura
Stock and Other Ownership Interests - Abbott; Johnson & Johnson; Regeneron (I)
Consulting or Advisory Role - Seagen
Travel, Accommodations, Expenses - Seagen
 
Paul R. Conkling
Employment - Virginia Oncology Associates
Research Funding - Aptose Biosciences (Inst); Arcus Biosciences (Inst); Astex Pharmaceuticals (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Janssen (Inst); Pfizer (Inst)
 
Victor Moreno
Employment - START
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Janssen Oncology; Merck
Speakers' Bureau - Bayer
Research Funding - Abbvie (Inst); ACEA Biosciences (Inst); Adaptimmune (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); E-therapeutics (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Menarini (Inst); Merck (Inst); Nanobiotix (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); PsiOxus Therapeutics (Inst); Puma Biotechnology (Inst); Regeneron (Inst); RigonTEC (Inst); Roche (Inst); Sanofi (Inst); Sierra Oncology (Inst); Synthon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tesaro (Inst); Transgene (Inst)
Expert Testimony - Medscape/Bayer; Nanobiotix
Travel, Accommodations, Expenses - Sanofi/Regeneron
Other Relationship - Bristol-Myers Squibb
 
William Jeffery Edenfield
Consulting or Advisory Role - Chimerix
 
Carlos Roberto Becerra
Honoraria - Taiho Pharmaceutical
Consulting or Advisory Role - Agenus; Bayer; HERON; Ipsen; SOBI; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Taiho Pharmaceutical
 
Sarina Anne Piha-Paul
Consulting or Advisory Role - Merck
Research Funding - Abbvie (Inst); Alkermes (Inst); Aminex (Inst); Amphivena Therapetics, Inc. (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Chugai Pharma (Inst); Curis (Inst); Daiichi Sankyo (Inst); Five Prime Therapeutics (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Helix BioPharma (Inst); Incyte (Inst); Jacobio (Inst); Lilly (Inst); MedImmune (Inst); Medivation (Inst); Merck Sharp and Dohme Corp. (Inst); New Link Genetics/BlueLink Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Pieris Pharmaceuticals (Inst); Principa Biopharma (Inst); Puma Biotechnology (Inst); RAPT Therapeutics (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Tesaro (Inst); TransThera Biosciences (Inst); XuanZhu (Inst)
 
Amy C. Peterson
Employment - BeiGene; CytomX Therapeutics
Leadership - BeiGene; CytomX Therapeutics
Stock and Other Ownership Interests - Agios; BeiGene; CytomX Therapeutics; Deciphera; Nektar
Consulting or Advisory Role - Gerson Lehrman Group
Patents, Royalties, Other Intellectual Property - Patent for development of a novel diagnostic assay in patients with triple negative breast cancer for the use of enzalutamide
Travel, Accommodations, Expenses - BeiGene; CytomX Therapeutics
 
Michelle Brown
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Lee P. James
Employment - Bristol-Myers Squibb; Pfizer
Stock and Other Ownership Interests - Bristol-Myers Squibb; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer
 
Ming Zheng
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Jieying Jiang
Employment - Bristol-Myers Squibb
 
Georgia Kollia
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Ailsa Swijter
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Paolo Antonio Ascierto
Stock and Other Ownership Interests - PrimeVax
Consulting or Advisory Role - 4SC; Alkermes; Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Genmab; Idera; Immunocore; Incyte; Italfarmaco; MedImmune; Merck Serono; Merck Sharp & Dohme; Nektar; Newlink Genetics; Novartis; Pierre Fabre; Roche/Genentech; Sandoz; Sanofi; Sun Pharma; Syndax; Ultimovacs
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme